Home
>
National Drug Code (NDC)
>
ApexiCon E
ApexiCon E - 10337-395-08 - (diflorasone diacetate)
Drug Information of ApexiCon E
| Product NDC: | 10337-395 |
| Proprietary Name: | ApexiCon E |
| Non Proprietary Name: | diflorasone diacetate |
| Active Ingredient(s): | .5 mg/g & nbsp; diflorasone diacetate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ApexiCon E
| Product NDC: | 10337-395 |
| Labeler Name: | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076263 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20021220 |
Package Information of ApexiCon E
| Package NDC: | 10337-395-08 |
| Package Description: | 2 g in 1 TUBE (10337-395-08) |
NDC Information of ApexiCon E
| NDC Code | 10337-395-08 |
| Proprietary Name | ApexiCon E |
| Package Description | 2 g in 1 TUBE (10337-395-08) |
| Product NDC | 10337-395 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | diflorasone diacetate |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20021220 |
| Marketing Category Name | ANDA |
| Labeler Name | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
| Substance Name | DIFLORASONE DIACETATE |
| Strength Number | .5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
